REFERENCES
- Gonzalez-Lopez JJ, Morcillo-Laiz R, Munoz-Negrete FJ. Adenoviral keratoconjunctivitis: an update. Arch Soc Esp Oftalmol. 2013;88:108–115.
- Tabbara KF, Omar N, Hammouda E, et al. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia. Mol Vis. 2010;16:2132–2136.
- Jones BR. The clinical features of viral keratitis and a concept of their pathogenesis. Proc R Soc Med. 1958;51:917–924.
- Meyer-Rüsenberg B, Loderstädt U, Richard G, et al. Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int. 2011;108:475–480.
- Levinger E, Slomovic A, Sansanayudh W, et al. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea. 2010;29:638–640.
- Bodor N, Buchwald P. Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. AAPS J. 2005;7:820–833.
- Awan MA, Agarwal PK, Watson DG, et al. Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance. Br J Ophthalmol. 2009;93:708–713.
- Weijtens O, Schoemaker RC, Romijn FP, et al. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology. 2002; 109:1887–1891.
- Romanowski EG, Roba LA, Wiley L, et al. The effects of corticosteroids of adenoviral replication. Arch Ophthalmol. 1996;114:581–585.
- Sahin A, Bozkurt B, Irkec M: Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up. Cornea. 2008;27:193–195.
- Doan S, Gabison E, Abitbol O, et al. Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid dependent vernal keratoconjunctivitis. J Fr Ophtalmol. 2007;30:697–701.
- Price MO, Feng MT, Scanameo A, et al. Loteprednol etabonate 0.5% gel vs. prednisolone acetate 1% solution after Descemet membrane endothelial keratoplasty: prospective randomized trial. Cornea. 2015;34:853–858.
- Razeghinejad MR, L. Katz J. Steroid-induced iatrogenic glaucoma. Ophthalmic Res. 2012;47:66–80.
- Jhanji V, Chan TC, Li EY, et al. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015;60:435–443.
- Laibson PR. Ocular adenoviral infections. Int Ophthalmol Clin. 1984;24:49–64.
- Montessori V, Scharf S, Holland S, et al. Epidemic keratoconjunctivitis outbreak at a tertiary referral eye clinic. Am J Infect Control. 1998;26:399–405.